Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Siva Nageswara Rao Gajula, Tanaaz Navin Nathani, Rashmi Madhukar Patil, Sasikala Talari & Rajesh Sonti. (2022) Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development. Drug Metabolism Reviews 54:4, pages 427-448.
Read now
Read now
Francesca Toselli, Melanie Golding, Johan Nicolaï, Eric Gillent & Hugues Chanteux. (2022) Drug clearance by aldehyde oxidase: can we avoid clinical failure?. Xenobiotica 52:8, pages 890-903.
Read now
Read now
Christine Beedham. (2020) Aldehyde oxidase; new approaches to old problems. Xenobiotica 50:1, pages 34-50.
Read now
Read now
Narges Cheshmazar, Siavoush Dastmalchi, Mineko Terao, Enrico Garattini & Maryam Hamzeh-Mivehroud. (2019) Aldehyde oxidase at the crossroad of metabolism and preclinical screening. Drug Metabolism Reviews 51:4, pages 428-452.
Read now
Read now
Maki Miyamoto, Shinji Iwasaki, Ikumi Chisaki, Sayaka Nakagawa, Nobuyuki Amano & Hideki Hirabayashi. (2017) Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver. Xenobiotica 47:12, pages 1052-1063.
Read now
Read now
Deepak Dalvie, Cathie Xiang, Ping Kang & Sue Zhou. (2013) Interspecies variation in the metabolism of zoniporide by aldehyde oxidase. Xenobiotica 43:5, pages 399-408.
Read now
Read now
James Matthew Hutzler, Ronald Scott Obach, Deepak Dalvie & Michael A Zientek. (2013) Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 153-168.
Read now
Read now
Federica Vacondio, Claudia Silva, Marco Mor & Bernard Testa. (2010) Qualitative structure-metabolism relationships in the hydrolysis of carbamates. Drug Metabolism Reviews 42:4, pages 551-589.
Read now
Read now
D. O’Connor, P. Jones, M. S. Chambers, R. Maxey, H. J. Szekeres, N. Szeto, P. Scott-Stevens, A. M. Macleod, M. Braun & B. Cato. (2006) Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist. Xenobiotica 36:4, pages 315-330.
Read now
Read now
D. J. P. Critchley, D. J. Rance & C. Beedham. (1994) Biotransformation of carbazeran in guinea pig: Effect of hydralazine pretreatment. Xenobiotica 24:1, pages 37-47.
Read now
Read now
Peter Dogterom, Gerhard Zbinden & Gerd K. Reznik. (1992) Cardiotoxicity of Vasodilators and Positive Inotropic/Vasodilating Drugs in Dogs: An Overview. Critical Reviews in Toxicology 22:3-4, pages 203-241.
Read now
Read now
Articles from other publishers (50)
Nihan Izat, Jayaprakasam Bolleddula, Armina Abbasi, Lionel Cheruzel, Robert S. Jones, Darren Moss, Fatima Ortega-Muro, Yannick Parmentier, Vincent C. Peterkin, Dan-Dan Tian, Karthik Venkatakrishnan, Michael A. Zientek, Jill Barber, J. Brian Houston, Aleksandra Galetin & Daniel Scotcher. (2023) Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation. Drug Metabolism and Disposition 51:12, pages 1591-1606.
Crossref
Crossref
Shotaro Uehara, Masahiko Yasuda, Yuichiro Higuchi, Nao Yoneda, Kenji Kawai, Masami Suzuki, Hiroshi Yamazaki & Hiroshi Suemizu. (2023) SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers. Toxicology Letters.
Crossref
Crossref
Kazuko Inoue, Kiyomi Kikuchi, Kazumi Takahashi, Seiji Hitaoka, Kazutomi Kusano & Takafumi Komori. (2023) In Vitro Metabolism of 2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl- 3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide (CP-724,714) by Aldehyde Oxidase and Predicting Its Percent Contribution Relative to CYP-Mediated Metabolism. Drug Metabolism and Disposition 51:8, pages 962-969.
Crossref
Crossref
Nanna Tynelius, Christoffer Bundgaard & Claudia E. Müller. (2023) Evaluation of a Five-Probe Metabolic Control Cocktail in Long-Term Cocultured Human Hepatocytes. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Mario Öeren, Peter J. WaltonJames SuriDavid J. Ponting, Peter A. Hunt & Matthew D. Segall. (2022) Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning. Journal of Medicinal Chemistry 65:20, pages 14066-14081.
Crossref
Crossref
Luca Docci, Nicolò Milani, Thomas Ramp, Andrea A. Romeo, Patricio Godoy, Daniela Ortiz Franyuti, Stephan Krähenbühl, Michael Gertz, Aleksandra Galetin, Neil Parrott & Stephen Fowler. (2022) Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies. Lab on a Chip 22:6, pages 1187-1205.
Crossref
Crossref
Kirk D. Kozminski, Jangir Selimkhanov, Scott Heyward & Michael A. Zientek. (2021) Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance. Drug Metabolism and Disposition 49:9, pages 743-749.
Crossref
Crossref
Ciarán N. Cronin, JianHua Liu, Nicole Grable, Timothy J. Strelevitz, R. Scott Obach & Anthony Carlo. (2021) Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay. Protein Expression and Purification 177, pages 105749.
Crossref
Crossref
Mari Davies, Prabha Peramuhendige, Lloyd King, Melanie Golding, Apoorva Kotian, Mark Penney, Syeda Shah & Nenad Manevski. (2020) Evaluation of In Vitro Models for Assessment of Human Intestinal Metabolism in Drug Discovery. Drug Metabolism and Disposition 48:11, pages 1169-1182.
Crossref
Crossref
Mailys De Sousa Mendes, Alexandra L. Orton, Helen E. Humphries, Barry Jones, Iain Gardner, Sibylle Neuhoff & Venkatesh Pilla Reddy. (2020) A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates. Drug Metabolism and Disposition 48:11, pages 1231-1238.
Crossref
Crossref
Suguru Kato, Abhi Shah, Mihaela Plesescu, Yoshinari Miyata, Jayaprakasam Bolleddula, Swapan Chowdhury & Xiaochun Zhu. (2020) Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 48:10, pages 934-943.
Crossref
Crossref
T. Eric Ballard, N. Kratochwil, Loretta M. Cox, Mark A. Moen, F. Klammers, A. Ekiciler, A. Goetschi & I. Walter. (2020) Simplifying the Execution of HepatoPac MetID Experiments: Metabolite Profile and Intrinsic Clearance Comparisons. Drug Metabolism and Disposition 48:9, pages 804-810.
Crossref
Crossref
Shotaro Uehara, Nao Yoneda, Yuichiro Higuchi, Hiroshi Yamazaki & Hiroshi Suemizu. (2020) Human Aldehyde Oxidase 1–Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes. Drug Metabolism and Disposition 48:7, pages 580-586.
Crossref
Crossref
Mineko Terao, Enrico Garattini, Maria João Romão & Silke Leimkühler. (2020) Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes. Journal of Biological Chemistry 295:16, pages 5377-5389.
Crossref
Crossref
Adrian J. Fretland, Tashinga E. Bapiro, Barry Jones, Roshini Markandu, Alexandra L. Orton & Venkatesh Pilla Reddy. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
213
236
.
Nenad Manevski, Lloyd King, William R. Pitt, Fabien Lecomte & Francesca Toselli. (2019) Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery. Journal of Medicinal Chemistry 62:24, pages 10955-10994.
Crossref
Crossref
Deepak Dalvie & Li Di. (2019) Aldehyde oxidase and its role as a drug metabolizing enzyme. Pharmacology & Therapeutics 201, pages 137-180.
Crossref
Crossref
Armina Abbasi, Erickson M. Paragas, Carolyn A. Joswig-Jones, John T. Rodgers & Jeffrey P. Jones. (2019) Time Course of Aldehyde Oxidase and Why It Is Nonlinear. Drug Metabolism and Disposition 47:5, pages 473-483.
Crossref
Crossref
Jiarong Xie, Nur Fazilah Saburulla, Shiyan Chen, Siew Ying Wong, Ze Ping Yap, Linghua Harris Zhang & Aik Jiang Lau. (2019)
Evaluation of Carbazeran 4-Oxidation and
O
6
-Benzylguanine 8-Oxidation as Catalytic Markers of Human Aldehyde Oxidase: Impact of Cytosolic Contamination of Liver Microsomes
. Drug Metabolism and Disposition 47:1, pages 26-37.
Crossref
Crossref
F. Oesch, E. Fabian & Robert Landsiedel. (2018) Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. Archives of Toxicology 92:8, pages 2411-2456.
Crossref
Crossref
Ryan A. Dick. (2018) Refinement of In Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Metabolites of Kinase Inhibitors. Drug Metabolism and Disposition 46:6, pages 846-859.
Crossref
Crossref
Gabriele Cruciani, Nicolò Milani, Paolo Benedetti, Susan Lepri, Lucia Cesarini, Massimo Baroni, Francesca Spyrakis, Sara Tortorella, Edoardo Mosconi & Laura Goracci. (2017) From Experiments to a Fast Easy-to-Use Computational Methodology to Predict Human Aldehyde Oxidase Selectivity and Metabolic Reactions. Journal of Medicinal Chemistry 61:1, pages 360-371.
Crossref
Crossref
E. Garattini & M. Terao. 2018. Comprehensive Toxicology. Comprehensive Toxicology
208
232
.
Erickson M. Paragas, Sara C. Humphreys, Joshua Min, Carolyn A. Joswig-Jones, Silke Leimkühler & Jeffrey P. Jones. (2017) ecoAO: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism. ACS Omega 2:8, pages 4820-4827.
Crossref
Crossref
David J. Wilkinson, Rosalind L. Southall, Mingguang Li, Lisa M. Wright, Lindsay J. Corfield, Thomas A. Heeley, Benjamin Bratby, Ranbir Mannu, Sarah L. Johnson, Victoria Shaw, Holly L. Friett, Louise A. Blakeburn, John S. Kendrick & Michael B. Otteneder. (2017) Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro–In Vivo Comparisons. The AAPS Journal 19:4, pages 1163-1174.
Crossref
Crossref
Susan Lepri, Martina CeccarelliNicolò MilaniSara TortorellaAndrea CuccoAurora Valeri, Laura GoracciAndreas Brink & Gabriele Cruciani. (2017)
Structure–metabolism relationships in
human-
AOX: Chemical insights from a large database of aza-aromatic and amide compounds
. Proceedings of the National Academy of Sciences 114:16.
Crossref
Crossref
Upendra A. Argikar, Philip M. Potter, J. Matthew Hutzler & Punit H. Marathe. (2016) Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance. The AAPS Journal 18:6, pages 1391-1405.
Crossref
Crossref
R. S. Foti & D. K. Dalvie. (2016) Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics. Drug Metabolism and Disposition 44:8, pages 1229-1245.
Crossref
Crossref
T. E. Ballard, S. Wang, L. M. Cox, M. A. Moen, S. Krzyzewski, O. Ukairo & R. S. Obach. (2015) Application of a Micropatterned Cocultured Hepatocyte System To Predict Preclinical and Human-Specific Drug Metabolism. Drug Metabolism and Disposition 44:2, pages 172-179.
Crossref
Crossref
Dennis A. Smith & Thomas A. Baillie. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry
83
105
.
J. Matthew Hutzler & Michael A. Zientek. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
79
130
.
Dennis A Smith. (2015) A new phase of drug discovery? The rise of PK/PD means extremely challenging work at the coalface. Bioanalysis 7:12, pages 1415-1417.
Crossref
Crossref
Seigo Sanoh, Yoshitaka Tayama, Kazumi Sugihara, Shigeyuki Kitamura & Shigeru Ohta. (2015) Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metabolism and Pharmacokinetics 30:1, pages 52-63.
Crossref
Crossref
Nenad Manevski, Kamal Kumar Balavenkatraman, Barbara Bertschi, Piet Swart, Markus Walles, Gian Camenisch, Hilmar Schiller, Olivier Kretz, Barbara Ling, Reto Wettstein, Dirk J. Schaefer, Francois Pognan, Armin Wolf & Karine Litherland. (2014) Aldehyde Oxidase Activity in Fresh Human Skin. Drug Metabolism and Disposition 42:12, pages 2049-2057.
Crossref
Crossref
J. Matthew Hutzler, Matthew A. Cerny, Young-Sun Yang, Constance Asher, Diane Wong, Kosea Frederick & Kyle Gilpin. (2014) Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the EGFR Inhibitor BIBX1382. Drug Metabolism and Disposition 42:10, pages 1751-1760.
Crossref
Crossref
J. Matthew Hutzler, Young-Sun Yang, Caitlin Brown, Scott Heyward & Timothy Moeller. (2014) Aldehyde Oxidase Activity in Donor-Matched Fresh and Cryopreserved Human Hepatocytes and Assessment of Variability in 75 Donors. Drug Metabolism and Disposition 42:6, pages 1090-1097.
Crossref
Crossref
Hengmiao Cheng, Chunze Li, Simon Bailey, Sangita M. Baxi, Lance Goulet, Lisa Guo, Jacqui Hoffman, Ying Jiang, Theodore Otto Johnson, Ted W. Johnson, Daniel R. Knighton, John Li, Kevin K.-C. Liu, Zhengyu Liu, Matthew A. Marx, Marlena Walls, Peter A. Wells, Min-Jean Yin, Jinjiang Zhu & Michael Zientek. (2012) Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Medicinal Chemistry Letters 4:1, pages 91-97.
Crossref
Crossref
Alexander V. LyubimovCornelis E. C. A. Hop. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
43
.
Alexander V. LyubimovMichael Zientek, Ping Kang, Matthew J. Hutzler & Scott R. Obach. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
59
.
Raman Sharma, Timothy J. Strelevitz, Hongying Gao, Alan J. Clark, Klaas Schildknegt, R. Scott Obach, Sharon L. Ripp, Douglas K. Spracklin, Larry M. Tremaine & Alfin D. N. Vaz. (2012) Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs. Drug Metabolism and Disposition 40:3, pages 625-634.
Crossref
Crossref
J. Matthew Hutzler, Young-Sun Yang, Daniel Albaugh, Cody L. Fullenwider, Jennifer Schmenk & Michael B. Fisher. (2012) Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes. Drug Metabolism and Disposition 40:2, pages 267-275.
Crossref
Crossref
Michael Zientek, Ying Jiang, Kuresh Youdim & R. Scott Obach. (2010) In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase. Drug Metabolism and Disposition 38:8, pages 1322-1327.
Crossref
Crossref
Angus NR Nedderman & Pat Wright. (2010) Looking back through the MIST: a perspective of evolving strategies and key focus areas for metabolite safety analysis. Bioanalysis 2:7, pages 1235-1248.
Crossref
Crossref
C. Beedham. 2010. Comprehensive Toxicology. Comprehensive Toxicology
185
205
.
Dennis A. Smith & R. Scott Obach. (2009) Metabolites in Safety Testing (MIST): Considerations of Mechanisms of Toxicity with Dose, Abundance, and Duration of Treatment. Chemical Research in Toxicology 22:2, pages 267-279.
Crossref
Crossref
Christine Beedham, Sally E. Bruce, David J. Critchley & David J. Rance. (1990) 1-Substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases. Biochemical Pharmacology 39:7, pages 1213-1221.
Crossref
Crossref
J. Elks & C. R. Ganellin. 1990. Dictionary of Drugs. Dictionary of Drugs
204
343
.
C. Beedham, S. E. Bruce, D. J. Critchley, Y. Al-Tayib & D. J. Rance. (1987) Species variation in hepatic aldehyde oxidase activity. European Journal of Drug Metabolism and Pharmacokinetics 12:4, pages 307-310.
Crossref
Crossref
Christine Beedham. 1987.
85
127
.
Christine Johnson, Christine Stubley-Beedham, J. Godfrey & P. Stell. (1985) Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochemical Pharmacology 34:24, pages 4251-4256.
Crossref
Crossref